Journals / Nöropsikiyatri Arşivi / 2021 / Cilt: 58 - Sayı: 2

Serum Brain-Derived Neurotrophic Factor, Glial-Derived Neurotrophic Factor, Nerve Growth Factor and Neurotrophin-3 Levels in Preschool Children with Language Disorder

Dil Bozukluğu Tanılı Okul Öncesi Çocuklarda Serum Beyin Kaynaklı Nörotrofik Faktör, Glial Hücre Kaynaklı Nörotrofik Faktör, Sinir Büyüme Faktörü ve Nörotrofin-3 Düzeyleri

Pages
128–132
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusions: These results suggest that low BDNF and NTF3 levels have independent negative relationships with LD, which could be contribute to etiopathogenesis of the disorder.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Accumulating studies demonstrate that neurotrophins may play a crucial role in a variety of neurodevelopmental disorders.
📊
Key Findings & Data:This study aimed to investigate serum brain-derived neurotrophic factor (BDNF), glialderived neurotrophic factor (GDNF), nerve growth factor (NGF) and neurotrophin-3 (NTF3) levels in preschool children with LD.
💡
Conclusion & Impact:Conclusions: These results suggest that low BDNF and NTF3 levels have independent negative relationships with LD, which could be contribute to etiopathogenesis of the disorder.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Introduction: Accumulating studies demonstrate that neurotrophins may play a crucial role in a variety of neurodevelopmental disorders. However, little data are available regarding the potential role of neurotrophins in language disorder (LD). This study aimed to investigate serum brain-derived neurotrophic factor (BDNF), glialderived neurotrophic factor (GDNF), nerve growth factor (NGF) and neurotrophin-3 (NTF3) levels in preschool children with LD. Methods: A total of 43 cases with LD and 43 healthy controls aged 18 to 60 months were enrolled in the study. The development levels and psychiatric symptoms of the children were determined by the Ankara Developmental Screening Inventory and Child Behavior Checklist 1.5–5, respectively. Serum neurotrophin levels were assessed by enzyme-linked immunosorbent assay kits. Results: Serum GDNF and NGF levels were significantly higher, serum BDNF and NTF3 levels were significantly lower in the LD group than in the control group. However, with logistic regression analyses, only negative relationship of BDNF and NTF3 levels with the presence of LD remained significant after accounting for the confounders including development level and coexisting psychiatric symptoms. Conclusions: These results suggest that low BDNF and NTF3 levels have independent negative relationships with LD, which could be contribute to etiopathogenesis of the disorder.

Özet

Amaç: Giderek artan miktarda çalışma nörotrofinlerin çok sayıdanörogelişimsel bozuklukta rol oynadığını göstermektedir. Bununlabirlikte, nörotrofinlerin dil bozukluğundaki (DB) rolü ile ilgili çok az bilgibulunmaktadır. Bu çalışmada, DB olan okul öncesi çocuklarda serumbeyin türevli nörotrofik faktör (BDNF), glial hücre türevli nörotrofik faktör(GDNF), sinir büyüme faktörü (NGF) ve nörotrofin-3 (NTF3) düzeylerininincelenmesi amaçlanmıştır.Yöntem: Yaşları 18–60 ay aralığında olan toplam 43 DB olgusu ve 43sağlıklı kontrol çalışmaya dahil edildi. Çocukların gelişim düzeyleriAnkara Gelişim Tarama Envanteri, psikiyatrik belirti şiddetleri ise ÇocukDavranışı Kontrol Listesi 1,5–5 aracılığıyla belirlendi. Serum nörotrofinseviyeleri immunosorbent assay test kitleri kullanılarak ölçüldü.Bulgular: DB grubunda kontrol grubuna göre, serum GDNF ve NGFdüzeyleri anlamlı olarak yüksek, serum BDNF ve NTF3 düzeyleri iseanlamlı olarak düşük bulundu. Bununla birlikte, lojistik regresyon analiziile gelişim düzeyi ve eşlik eden psikiyatrik semptomlar gibi karıştırıcıdeğişkenler kontrol edildiğinde yalnızca BDNF ve NTF3 düzeyleri ile DBarasındaki negatif ilişkinin anlamlı olarak kaldığı görüldü.Sonuç: Bu çalışma düşük serum BDNF ve NTF3 seviyelerinin LD ilebağımsız bir ilişki gösterebileceğini ortaya koymuştur.

🔖

Cite This Article

BİLGİÇ, A., FERAHKAYA, H., KILINÇ, İ., ENERGİN, V. M. (2021). Serum Brain-Derived Neurotrophic Factor, Glial-Derived Neurotrophic Factor, Nerve Growth Factor and Neurotrophin-3 Levels in Preschool Children with Language Disorder. Nöropsikiyatri Arşivi, Cilt: 58 - Sayı: 2, 128–132. https://ajindex.com/articles/340775

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. McLeod S, McKinnon DH. Prevalence of communication disorders compared with other learning needs in 14, 500 primary and secondary school students. Int J Lang Commun Disord 2007;42 Suppl 1:37–59. [CrossRef] 2. Morgan A, Fisher SE, Scheffer I, Hildebrand M. FOXP2-related speech and language disorders. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A. GeneReviews ((R)). Seattle (WA): University of Washington, Seattle; 1993–2021. 3. Centanni TM, Sanmann JN, Green JR, Iuzzini-Seigel J, Bartlett C, Sanger WG, Hogan TP. The role of candidate-gene CNTNAP2 in childhood apraxia of speech and specific language impairment. Am J Med Genet B Neuropsychiatr Genet 2015;168:536–543. [CrossRef] 4. Kalnak N, Stamouli S, Peyrard-Janvid M, Rabkina I, Becker M, Klingberg T, Kere J, Forssberg H, Tammimies K. Enrichment of rare copy number variation in children with developmental language disorder. Clin Genet 2018;94:313– 320. [CrossRef] 5. Liegeois F, Mayes A, Morgan A. Neural correlates of developmental speech and language disorders: evidence from neuroimaging. Curr Dev Disord Rep 2014;1:215–227. [CrossRef] 6. Lee MH, O’Hara NB, Behen ME, Jeong JW. Altered efficiency of white matter connections for language function in children with language disorder. Brain Lang 2020;203:104743. [CrossRef] 7. Simmons TR, Flax JF, Azaro MA, Hayter JE, Justice LM, Petrill SA, Bassett AS, Tallal P, Brzustowicz LM, Bartlett CW. Increasing genotype-phenotype model determinism: application to bivariate reading/language traits and epistatic interactions in language-impaired families. Hum Hered 2010;70:232–244. [CrossRef] 8. Egan MF, Kojima M, Callicott JH, Goldberg TE, Kolachana BS, Bertolino A, Zaitsev E, Gold B, Goldman D, Dean M, Lu B, Weinberger DR. The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 2003;112:257–269. [CrossRef] 9. Armeanu R, Mokkonen M, Crespi B. Meta-analysis of BDNF levels in autism. Cell Mol Neurobiol 2017;37:949–54. [CrossRef] 10. Sargin E, Pekcanlar Akay A, Resmi H, Alsen Cengizhan S, Özek Erkuran H, Ellidokuz H, Miral S, Orçin E. Evaluation of serum brain-derived neurotrophic factor levels in children with attention deficit hyperactivity disorder: preliminary data. Noro Psikiyatr Ars 2012;49:96–101. [CrossRef] 11. Saghazadeh A, Rezaei N. Brain-derived neurotrophic factor levels in autism: a systematic review and meta-analysis. J Autism Dev Disord 2017;47:1018– 1029. [Cro